Corinne E. Augelli-Szafran, Ph.D.

Vice President of Scientific Platforms

caugelli-szafran@southernresearch.org

Augelli-Szafran brings more than 25 years of practical and managerial experience in medicinal chemistry and drug discovery gained from leading research programs at institutions and pharmaceutical companies. Prior to joining Southern Research, Augelli-Szafran was director of the Laboratory for Experimental Alzheimer’s Drugs at Harvard Medical School and Brigham and Women’s Hospital in Boston. In that position, she built a fully functional medicinal chemistry and drug discovery laboratory focused on the development of gamma-secretase Notch-sparing inhibitors for the therapeutic indication of Alzheimer’s disease. Prior to Harvard, Augelli-Szafran held a number of leadership roles at Parke-Davis Pharmaceutical Research and Pfizer Global Research and Development. As co-chair and project leader, she investigated central nervous system therapeutics with an emphasis in neurodegeneration, mainly in Alzheimer’s disease therapeutics, but also in the areas of cardiovascular, atherosclerosis, psychotherapeutics, and inflammation and pain.

Related Articles

Southern Research breaks ground on new biotech center and campus renovations

Southern Research breaks ground on new biotech center and campus renovations

May 16, 2022 | Southern Research

Birmingham, Ala. – Southern Research today broke ground on a flagship biotech center that will anchor the development of 200,000 square feet of new or renovated wet lab space for life sciences. The new facility, located on the corner of R...
Read More
Southern Research announces new key additions to staff, leadership team

Southern Research announces new key additions to staff, leadership team

January 18, 2022 | Southern Research

Southern Research today announced key additions to its staff and leadership team. Brantley Fry has joined the organization as its new vice president of People and Community. Fry served as state director for former U.S. Sen. Doug Jones and most recently has worked as chief of staff and general ...
Read More
Southern Research and Tonix Pharmaceuticals Reports Positive COVID-19 Vaccine Efficacy Results

Southern Research and Tonix Pharmaceuticals Reports Positive COVID-19 Vaccine Efficacy Results

March 25, 2021 | Southern Research

Vaccine Candidate TNX-1800 Protected Both Upper and Lower Airways After Challenge with SARS-CoV-2, Suggesting an Ability to Block Forward Transmission   TNX-1800 is Based on a Proprietary Vaccine Platform Designed to Stimulate Long Term T cell...
Read More